FindTrial
Sign In

Parallel single-cell sequencing in ART

Parallel single-cell sequencing in ART

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047684
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-06-21
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility

Interventions

Gold Standard:Clinical outcome
Index test:Parallel&#32
single-cell&#32
sequencing

Sponsors

Shanghai Tongji Hosipital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Patients of reproductive age who met the diagnostic criteria of PCOS in China in 2011 were 22-39 years old.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with POI or POR; 2. Ovulation induction cycles >=3 times; 3. BMI >=35 kg/?; 4. Follicle stimulating hormone (FSH)>25IU/L; 5. Endometriosis; 6. Chromosomal abnormalities and other diseases that affect egg quality.

Design outcomes

Primary

MeasureTime frame
Pregnancy outcomes;Target genes expressions;—

Contacts

Public ContactWang Yanqiu

Shanghai Tongjii Hospital

wangfan2002@126.com+86 13585809660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026